nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—Phenytoin—epilepsy syndrome	0.334	1	CrCtD
Benzphetamine—ADRA2A—epilepsy syndrome	0.112	1	CbGaD
Benzphetamine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0168	0.0942	CbGbCtD
Benzphetamine—Phenytoin—Fosphenytoin—epilepsy syndrome	0.0166	0.0636	CrCrCtD
Benzphetamine—Phenytoin—Primidone—epilepsy syndrome	0.0166	0.0636	CrCrCtD
Benzphetamine—Phenylbutazone—Fosphenytoin—epilepsy syndrome	0.0159	0.0609	CrCrCtD
Benzphetamine—CYP2B6—Clobazam—epilepsy syndrome	0.0146	0.0817	CbGbCtD
Benzphetamine—Phenytoin—Phenobarbital—epilepsy syndrome	0.0123	0.0469	CrCrCtD
Benzphetamine—CYP2B6—Carbamazepine—epilepsy syndrome	0.0121	0.0677	CbGbCtD
Benzphetamine—Oxaprozin—Phenytoin—epilepsy syndrome	0.0114	0.0436	CrCrCtD
Benzphetamine—CYP2B6—Primidone—epilepsy syndrome	0.0113	0.0632	CbGbCtD
Benzphetamine—Phenylbutazone—Phenytoin—epilepsy syndrome	0.0109	0.0418	CrCrCtD
Benzphetamine—CYP2B6—Phenytoin—epilepsy syndrome	0.0108	0.0607	CbGbCtD
Benzphetamine—Phenytoin—Carbamazepine—epilepsy syndrome	0.0105	0.0402	CrCrCtD
Benzphetamine—Oxaprozin—Carbamazepine—epilepsy syndrome	0.0105	0.0402	CrCrCtD
Benzphetamine—CYP2B6—Propofol—epilepsy syndrome	0.0101	0.0566	CbGbCtD
Benzphetamine—Phenprocoumon—Phenytoin—epilepsy syndrome	0.0101	0.0386	CrCrCtD
Benzphetamine—Modafinil—Fosphenytoin—epilepsy syndrome	0.00977	0.0374	CrCrCtD
Benzphetamine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00964	0.0541	CbGbCtD
Benzphetamine—CYP2B6—Midazolam—epilepsy syndrome	0.00951	0.0534	CbGbCtD
Benzphetamine—CYP2B6—Diazepam—epilepsy syndrome	0.00914	0.0513	CbGbCtD
Benzphetamine—Antazoline—Phenytoin—epilepsy syndrome	0.00906	0.0346	CrCrCtD
Benzphetamine—Phenylbutazone—Clobazam—epilepsy syndrome	0.0089	0.034	CrCrCtD
Benzphetamine—Dextroamphetamine—Lacosamide—epilepsy syndrome	0.00864	0.0331	CrCrCtD
Benzphetamine—Amphetamine—Lacosamide—epilepsy syndrome	0.00864	0.0331	CrCrCtD
Benzphetamine—Methamphetamine—Lacosamide—epilepsy syndrome	0.00839	0.0321	CrCrCtD
Benzphetamine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.00761	0.0291	CrCrCtD
Benzphetamine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00721	0.0404	CbGbCtD
Benzphetamine—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.00681	0.026	CrCrCtD
Benzphetamine—Modafinil—Phenytoin—epilepsy syndrome	0.0067	0.0256	CrCrCtD
Benzphetamine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.00633	0.0242	CrCrCtD
Benzphetamine—Trimipramine—Carbamazepine—epilepsy syndrome	0.00618	0.0236	CrCrCtD
Benzphetamine—Modafinil—Carbamazepine—epilepsy syndrome	0.00618	0.0236	CrCrCtD
Benzphetamine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0059	0.0331	CbGbCtD
Benzphetamine—Modafinil—Oxcarbazepine—epilepsy syndrome	0.00569	0.0218	CrCrCtD
Benzphetamine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00569	0.0218	CrCrCtD
Benzphetamine—CYP3A4—Felbamate—epilepsy syndrome	0.00549	0.0308	CbGbCtD
Benzphetamine—CYP3A4—Trimethadione—epilepsy syndrome	0.00549	0.0308	CbGbCtD
Benzphetamine—Promethazine—Carbamazepine—epilepsy syndrome	0.00524	0.0201	CrCrCtD
Benzphetamine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00516	0.0289	CbGbCtD
Benzphetamine—Alimemazine—Carbamazepine—epilepsy syndrome	0.00515	0.0197	CrCrCtD
Benzphetamine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00483	0.0185	CrCrCtD
Benzphetamine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00474	0.0181	CrCrCtD
Benzphetamine—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.00466	0.0178	CrCrCtD
Benzphetamine—CYP3A4—Clonazepam—epilepsy syndrome	0.00466	0.0262	CbGbCtD
Benzphetamine—CYP3A4—Clobazam—epilepsy syndrome	0.00447	0.0251	CbGbCtD
Benzphetamine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00447	0.0171	CrCrCtD
Benzphetamine—Promazine—Carbamazepine—epilepsy syndrome	0.00443	0.017	CrCrCtD
Benzphetamine—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0043	0.0165	CrCrCtD
Benzphetamine—Promazine—Oxcarbazepine—epilepsy syndrome	0.00409	0.0156	CrCrCtD
Benzphetamine—CYP3A4—Rufinamide—epilepsy syndrome	0.0038	0.0213	CbGbCtD
Benzphetamine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00371	0.0208	CbGbCtD
Benzphetamine—CYP3A4—Primidone—epilepsy syndrome	0.00346	0.0194	CbGbCtD
Benzphetamine—CYP3A4—Phenytoin—epilepsy syndrome	0.00332	0.0186	CbGbCtD
Benzphetamine—CYP3A4—Propofol—epilepsy syndrome	0.0031	0.0174	CbGbCtD
Benzphetamine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00296	0.0166	CbGbCtD
Benzphetamine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00296	0.0166	CbGbCtD
Benzphetamine—CYP3A4—Midazolam—epilepsy syndrome	0.00292	0.0164	CbGbCtD
Benzphetamine—CYP3A4—Diazepam—epilepsy syndrome	0.00281	0.0158	CbGbCtD
Benzphetamine—CYP3A4—Zonisamide—epilepsy syndrome	0.00274	0.0154	CbGbCtD
Benzphetamine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00221	0.0124	CbGbCtD
Benzphetamine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00215	0.102	CbGeAlD
Benzphetamine—CYP3A4—Topiramate—epilepsy syndrome	0.002	0.0112	CbGbCtD
Benzphetamine—SLC18A2—telencephalic ventricle—epilepsy syndrome	0.00167	0.0795	CbGeAlD
Benzphetamine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00126	0.0601	CbGeAlD
Benzphetamine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00114	0.0543	CbGeAlD
Benzphetamine—SLC18A2—ganglion—epilepsy syndrome	0.00104	0.0495	CbGeAlD
Benzphetamine—SLC6A3—ganglion—epilepsy syndrome	0.000786	0.0374	CbGeAlD
Benzphetamine—SLC6A2—ganglion—epilepsy syndrome	0.000634	0.0302	CbGeAlD
Benzphetamine—SLC6A3—hindbrain—epilepsy syndrome	0.000596	0.0284	CbGeAlD
Benzphetamine—SLC18A2—brainstem—epilepsy syndrome	0.000452	0.0215	CbGeAlD
Benzphetamine—ADRA1A—hindbrain—epilepsy syndrome	0.000447	0.0213	CbGeAlD
Benzphetamine—SLC18A2—forebrain—epilepsy syndrome	0.000436	0.0208	CbGeAlD
Benzphetamine—SLC18A2—telencephalon—epilepsy syndrome	0.000401	0.0191	CbGeAlD
Benzphetamine—SLC6A3—brainstem—epilepsy syndrome	0.000342	0.0163	CbGeAlD
Benzphetamine—POR—medulla oblongata—epilepsy syndrome	0.000331	0.0157	CbGeAlD
Benzphetamine—SLC6A3—forebrain—epilepsy syndrome	0.00033	0.0157	CbGeAlD
Benzphetamine—SLC18A2—medulla oblongata—epilepsy syndrome	0.000315	0.015	CbGeAlD
Benzphetamine—SLC6A3—telencephalon—epilepsy syndrome	0.000303	0.0144	CbGeAlD
Benzphetamine—POR—midbrain—epilepsy syndrome	0.000302	0.0144	CbGeAlD
Benzphetamine—POR—spinal cord—epilepsy syndrome	0.000295	0.014	CbGeAlD
Benzphetamine—SLC18A2—midbrain—epilepsy syndrome	0.000288	0.0137	CbGeAlD
Benzphetamine—SLC6A2—brainstem—epilepsy syndrome	0.000276	0.0131	CbGeAlD
Benzphetamine—SLC6A2—forebrain—epilepsy syndrome	0.000266	0.0127	CbGeAlD
Benzphetamine—ADRA1A—brainstem—epilepsy syndrome	0.000256	0.0122	CbGeAlD
Benzphetamine—SLC18A2—head—epilepsy syndrome	0.00025	0.0119	CbGeAlD
Benzphetamine—ADRA1A—forebrain—epilepsy syndrome	0.000247	0.0118	CbGeAlD
Benzphetamine—SLC6A2—telencephalon—epilepsy syndrome	0.000245	0.0116	CbGeAlD
Benzphetamine—SLC18A2—nervous system—epilepsy syndrome	0.000237	0.0113	CbGeAlD
Benzphetamine—POR—cerebellum—epilepsy syndrome	0.000234	0.0111	CbGeAlD
Benzphetamine—SLC18A2—central nervous system—epilepsy syndrome	0.000228	0.0108	CbGeAlD
Benzphetamine—ADRA1A—telencephalon—epilepsy syndrome	0.000227	0.0108	CbGeAlD
Benzphetamine—SLC18A2—cerebellum—epilepsy syndrome	0.000223	0.0106	CbGeAlD
Benzphetamine—SLC6A3—midbrain—epilepsy syndrome	0.000218	0.0104	CbGeAlD
Benzphetamine—SLC6A3—spinal cord—epilepsy syndrome	0.000212	0.0101	CbGeAlD
Benzphetamine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000192	0.00915	CbGeAlD
Benzphetamine—POR—brain—epilepsy syndrome	0.00019	0.00903	CbGeAlD
Benzphetamine—SLC6A3—head—epilepsy syndrome	0.000189	0.00899	CbGeAlD
Benzphetamine—ADRA2A—forebrain—epilepsy syndrome	0.000188	0.00895	CbGeAlD
Benzphetamine—SLC18A2—brain—epilepsy syndrome	0.000181	0.00861	CbGeAlD
Benzphetamine—SLC6A3—nervous system—epilepsy syndrome	0.000179	0.00852	CbGeAlD
Benzphetamine—ADRA2A—telencephalon—epilepsy syndrome	0.000173	0.00823	CbGeAlD
Benzphetamine—SLC6A3—central nervous system—epilepsy syndrome	0.000172	0.0082	CbGeAlD
Benzphetamine—SLC6A3—cerebellum—epilepsy syndrome	0.000168	0.00802	CbGeAlD
Benzphetamine—Decreased appetite—Acetazolamide—epilepsy syndrome	0.000153	0.00313	CcSEcCtD
Benzphetamine—SLC6A2—head—epilepsy syndrome	0.000152	0.00725	CbGeAlD
Benzphetamine—Tremor—Phenytoin—epilepsy syndrome	0.000152	0.00312	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000152	0.00311	CcSEcCtD
Benzphetamine—Tremor—Oxcarbazepine—epilepsy syndrome	0.000151	0.0031	CcSEcCtD
Benzphetamine—Anorexia—Levetiracetam—epilepsy syndrome	0.00015	0.00308	CcSEcCtD
Benzphetamine—Agitation—Clonazepam—epilepsy syndrome	0.00015	0.00308	CcSEcCtD
Benzphetamine—Palpitations—Zonisamide—epilepsy syndrome	0.00015	0.00307	CcSEcCtD
Benzphetamine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.00015	0.00307	CcSEcCtD
Benzphetamine—Agitation—Phenytoin—epilepsy syndrome	0.000149	0.00306	CcSEcCtD
Benzphetamine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000149	0.00304	CcSEcCtD
Benzphetamine—Agitation—Oxcarbazepine—epilepsy syndrome	0.000148	0.00304	CcSEcCtD
Benzphetamine—Diarrhoea—Rufinamide—epilepsy syndrome	0.000148	0.00303	CcSEcCtD
Benzphetamine—Nausea—Trimethadione—epilepsy syndrome	0.000148	0.00303	CcSEcCtD
Benzphetamine—Insomnia—Propofol—epilepsy syndrome	0.000148	0.00303	CcSEcCtD
Benzphetamine—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.000147	0.00302	CcSEcCtD
Benzphetamine—Sweating—Valproic Acid—epilepsy syndrome	0.000146	0.00299	CcSEcCtD
Benzphetamine—Dizziness—Phenobarbital—epilepsy syndrome	0.000146	0.00299	CcSEcCtD
Benzphetamine—Tremor—Carbamazepine—epilepsy syndrome	0.000145	0.00297	CcSEcCtD
Benzphetamine—Anorexia—Fosphenytoin—epilepsy syndrome	0.000145	0.00297	CcSEcCtD
Benzphetamine—SLC6A2—nervous system—epilepsy syndrome	0.000144	0.00687	CbGeAlD
Benzphetamine—Palpitations—Clonazepam—epilepsy syndrome	0.000144	0.00296	CcSEcCtD
Benzphetamine—Palpitations—Phenytoin—epilepsy syndrome	0.000143	0.00294	CcSEcCtD
Benzphetamine—Dizziness—Rufinamide—epilepsy syndrome	0.000143	0.00293	CcSEcCtD
Benzphetamine—Palpitations—Oxcarbazepine—epilepsy syndrome	0.000143	0.00292	CcSEcCtD
Benzphetamine—Insomnia—Levetiracetam—epilepsy syndrome	0.000143	0.00292	CcSEcCtD
Benzphetamine—Tachycardia—Diazepam—epilepsy syndrome	0.000143	0.00292	CcSEcCtD
Benzphetamine—Agitation—Carbamazepine—epilepsy syndrome	0.000142	0.00292	CcSEcCtD
Benzphetamine—ADRA1A—head—epilepsy syndrome	0.000142	0.00674	CbGeAlD
Benzphetamine—Hyperhidrosis—Diazepam—epilepsy syndrome	0.000141	0.00289	CcSEcCtD
Benzphetamine—Dyspepsia—Midazolam—epilepsy syndrome	0.000141	0.00288	CcSEcCtD
Benzphetamine—Tremor—Lamotrigine—epilepsy syndrome	0.00014	0.00288	CcSEcCtD
Benzphetamine—Urticaria—Acetazolamide—epilepsy syndrome	0.00014	0.00286	CcSEcCtD
Benzphetamine—Anorexia—Diazepam—epilepsy syndrome	0.000139	0.00285	CcSEcCtD
Benzphetamine—SLC6A2—central nervous system—epilepsy syndrome	0.000139	0.00662	CbGeAlD
Benzphetamine—Diarrhoea—Lacosamide—epilepsy syndrome	0.000139	0.00285	CcSEcCtD
Benzphetamine—Dyspepsia—Levetiracetam—epilepsy syndrome	0.000139	0.00285	CcSEcCtD
Benzphetamine—Headache—Phenobarbital—epilepsy syndrome	0.000138	0.00283	CcSEcCtD
Benzphetamine—Tachycardia—Felbamate—epilepsy syndrome	0.000138	0.00283	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000138	0.00283	CcSEcCtD
Benzphetamine—Insomnia—Fosphenytoin—epilepsy syndrome	0.000138	0.00282	CcSEcCtD
Benzphetamine—Agitation—Lamotrigine—epilepsy syndrome	0.000138	0.00282	CcSEcCtD
Benzphetamine—Decreased appetite—Levetiracetam—epilepsy syndrome	0.000137	0.00281	CcSEcCtD
Benzphetamine—SLC6A3—brain—epilepsy syndrome	0.000137	0.00651	CbGeAlD
Benzphetamine—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000137	0.0028	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000136	0.00279	CcSEcCtD
Benzphetamine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000136	0.00647	CbGeAlD
Benzphetamine—Headache—Rufinamide—epilepsy syndrome	0.000136	0.00278	CcSEcCtD
Benzphetamine—Tachycardia—Zonisamide—epilepsy syndrome	0.000135	0.00277	CcSEcCtD
Benzphetamine—Diarrhoea—Clobazam—epilepsy syndrome	0.000135	0.00276	CcSEcCtD
Benzphetamine—Anorexia—Felbamate—epilepsy syndrome	0.000135	0.00276	CcSEcCtD
Benzphetamine—Psychotic disorder—Topiramate—epilepsy syndrome	0.000135	0.00276	CcSEcCtD
Benzphetamine—Dizziness—Lacosamide—epilepsy syndrome	0.000134	0.00275	CcSEcCtD
Benzphetamine—ADRA1A—nervous system—epilepsy syndrome	0.000134	0.00639	CbGeAlD
Benzphetamine—Insomnia—Vigabatrin—epilepsy syndrome	0.000134	0.00275	CcSEcCtD
Benzphetamine—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.000134	0.00275	CcSEcCtD
Benzphetamine—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000134	0.00274	CcSEcCtD
Benzphetamine—Palpitations—Lamotrigine—epilepsy syndrome	0.000132	0.00271	CcSEcCtD
Benzphetamine—Decreased appetite—Fosphenytoin—epilepsy syndrome	0.000132	0.00271	CcSEcCtD
Benzphetamine—Insomnia—Diazepam—epilepsy syndrome	0.000132	0.00271	CcSEcCtD
Benzphetamine—Sweating—Pregabalin—epilepsy syndrome	0.000132	0.0027	CcSEcCtD
Benzphetamine—Anorexia—Zonisamide—epilepsy syndrome	0.000132	0.0027	CcSEcCtD
Benzphetamine—Nausea—Phenobarbital—epilepsy syndrome	0.000131	0.00268	CcSEcCtD
Benzphetamine—Dyspepsia—Vigabatrin—epilepsy syndrome	0.000131	0.00268	CcSEcCtD
Benzphetamine—Dizziness—Clobazam—epilepsy syndrome	0.00013	0.00267	CcSEcCtD
Benzphetamine—Tachycardia—Clonazepam—epilepsy syndrome	0.00013	0.00267	CcSEcCtD
Benzphetamine—Urticaria—Propofol—epilepsy syndrome	0.00013	0.00266	CcSEcCtD
Benzphetamine—Tachycardia—Phenytoin—epilepsy syndrome	0.000129	0.00265	CcSEcCtD
Benzphetamine—ADRA1A—central nervous system—epilepsy syndrome	0.000129	0.00615	CbGeAlD
Benzphetamine—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000129	0.00264	CcSEcCtD
Benzphetamine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000129	0.00264	CcSEcCtD
Benzphetamine—Dyspepsia—Diazepam—epilepsy syndrome	0.000129	0.00264	CcSEcCtD
Benzphetamine—Nausea—Rufinamide—epilepsy syndrome	0.000129	0.00263	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000128	0.00263	CcSEcCtD
Benzphetamine—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000128	0.00262	CcSEcCtD
Benzphetamine—Insomnia—Felbamate—epilepsy syndrome	0.000128	0.00262	CcSEcCtD
Benzphetamine—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000127	0.00261	CcSEcCtD
Benzphetamine—Headache—Lacosamide—epilepsy syndrome	0.000127	0.00261	CcSEcCtD
Benzphetamine—Anorexia—Clonazepam—epilepsy syndrome	0.000127	0.00261	CcSEcCtD
Benzphetamine—Decreased appetite—Diazepam—epilepsy syndrome	0.000127	0.0026	CcSEcCtD
Benzphetamine—Urticaria—Midazolam—epilepsy syndrome	0.000127	0.0026	CcSEcCtD
Benzphetamine—ADRA1A—cerebellum—epilepsy syndrome	0.000126	0.00601	CbGeAlD
Benzphetamine—Anorexia—Phenytoin—epilepsy syndrome	0.000126	0.00259	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000126	0.00258	CcSEcCtD
Benzphetamine—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000126	0.00257	CcSEcCtD
Benzphetamine—Insomnia—Zonisamide—epilepsy syndrome	0.000125	0.00257	CcSEcCtD
Benzphetamine—Dyspepsia—Felbamate—epilepsy syndrome	0.000124	0.00255	CcSEcCtD
Benzphetamine—ADRA2A—midbrain—epilepsy syndrome	0.000124	0.00591	CbGeAlD
Benzphetamine—Headache—Clobazam—epilepsy syndrome	0.000124	0.00253	CcSEcCtD
Benzphetamine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000123	0.00253	CcSEcCtD
Benzphetamine—Decreased appetite—Felbamate—epilepsy syndrome	0.000123	0.00252	CcSEcCtD
Benzphetamine—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000122	0.00251	CcSEcCtD
Benzphetamine—Dyspepsia—Zonisamide—epilepsy syndrome	0.000122	0.0025	CcSEcCtD
Benzphetamine—ADRA2A—spinal cord—epilepsy syndrome	0.000121	0.00577	CbGeAlD
Benzphetamine—Sweating—Gabapentin—epilepsy syndrome	0.000121	0.00248	CcSEcCtD
Benzphetamine—Urticaria—Fosphenytoin—epilepsy syndrome	0.000121	0.00248	CcSEcCtD
Benzphetamine—Nausea—Lacosamide—epilepsy syndrome	0.000121	0.00247	CcSEcCtD
Benzphetamine—Insomnia—Clonazepam—epilepsy syndrome	0.000121	0.00247	CcSEcCtD
Benzphetamine—Anorexia—Carbamazepine—epilepsy syndrome	0.000121	0.00247	CcSEcCtD
Benzphetamine—Decreased appetite—Zonisamide—epilepsy syndrome	0.00012	0.00247	CcSEcCtD
Benzphetamine—Diarrhoea—Acetazolamide—epilepsy syndrome	0.00012	0.00246	CcSEcCtD
Benzphetamine—Insomnia—Phenytoin—epilepsy syndrome	0.00012	0.00246	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000119	0.00245	CcSEcCtD
Benzphetamine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000119	0.00244	CcSEcCtD
Benzphetamine—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000119	0.00244	CcSEcCtD
Benzphetamine—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000118	0.00242	CcSEcCtD
Benzphetamine—Urticaria—Vigabatrin—epilepsy syndrome	0.000118	0.00242	CcSEcCtD
Benzphetamine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000118	0.00241	CcSEcCtD
Benzphetamine—Dyspepsia—Clonazepam—epilepsy syndrome	0.000117	0.00241	CcSEcCtD
Benzphetamine—Nausea—Clobazam—epilepsy syndrome	0.000117	0.0024	CcSEcCtD
Benzphetamine—Dyspepsia—Phenytoin—epilepsy syndrome	0.000117	0.00239	CcSEcCtD
Benzphetamine—Anorexia—Lamotrigine—epilepsy syndrome	0.000117	0.00239	CcSEcCtD
Benzphetamine—Dizziness—Acetazolamide—epilepsy syndrome	0.000116	0.00238	CcSEcCtD
Benzphetamine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000116	0.00238	CcSEcCtD
Benzphetamine—Urticaria—Diazepam—epilepsy syndrome	0.000116	0.00238	CcSEcCtD
Benzphetamine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000116	0.00238	CcSEcCtD
Benzphetamine—Decreased appetite—Clonazepam—epilepsy syndrome	0.000116	0.00238	CcSEcCtD
Benzphetamine—Decreased appetite—Phenytoin—epilepsy syndrome	0.000115	0.00236	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000115	0.00236	CcSEcCtD
Benzphetamine—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000115	0.00235	CcSEcCtD
Benzphetamine—Insomnia—Carbamazepine—epilepsy syndrome	0.000114	0.00234	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000114	0.00234	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000114	0.00233	CcSEcCtD
Benzphetamine—Urticaria—Felbamate—epilepsy syndrome	0.000112	0.0023	CcSEcCtD
Benzphetamine—CYP2B6—head—epilepsy syndrome	0.000112	0.00534	CbGeAlD
Benzphetamine—Diarrhoea—Propofol—epilepsy syndrome	0.000112	0.00229	CcSEcCtD
Benzphetamine—Tremor—Valproic Acid—epilepsy syndrome	0.000111	0.00228	CcSEcCtD
Benzphetamine—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000111	0.00228	CcSEcCtD
Benzphetamine—Insomnia—Lamotrigine—epilepsy syndrome	0.000111	0.00227	CcSEcCtD
Benzphetamine—SLC6A2—brain—epilepsy syndrome	0.00011	0.00525	CbGeAlD
Benzphetamine—Headache—Acetazolamide—epilepsy syndrome	0.00011	0.00226	CcSEcCtD
Benzphetamine—Urticaria—Zonisamide—epilepsy syndrome	0.00011	0.00225	CcSEcCtD
Benzphetamine—Decreased appetite—Carbamazepine—epilepsy syndrome	0.00011	0.00225	CcSEcCtD
Benzphetamine—Agitation—Valproic Acid—epilepsy syndrome	0.000109	0.00224	CcSEcCtD
Benzphetamine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000109	0.00224	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000109	0.00224	CcSEcCtD
Benzphetamine—Dizziness—Propofol—epilepsy syndrome	0.000108	0.00221	CcSEcCtD
Benzphetamine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000108	0.00221	CcSEcCtD
Benzphetamine—ADRA2A—head—epilepsy syndrome	0.000108	0.00513	CbGeAlD
Benzphetamine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000108	0.00221	CcSEcCtD
Benzphetamine—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000108	0.0022	CcSEcCtD
Benzphetamine—CYP2B6—nervous system—epilepsy syndrome	0.000106	0.00507	CbGeAlD
Benzphetamine—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000106	0.00218	CcSEcCtD
Benzphetamine—Urticaria—Clonazepam—epilepsy syndrome	0.000106	0.00217	CcSEcCtD
Benzphetamine—Dizziness—Midazolam—epilepsy syndrome	0.000106	0.00216	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000106	0.00216	CcSEcCtD
Benzphetamine—Urticaria—Phenytoin—epilepsy syndrome	0.000105	0.00216	CcSEcCtD
Benzphetamine—Palpitations—Valproic Acid—epilepsy syndrome	0.000105	0.00216	CcSEcCtD
Benzphetamine—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000105	0.00215	CcSEcCtD
Benzphetamine—Nausea—Acetazolamide—epilepsy syndrome	0.000104	0.00214	CcSEcCtD
Benzphetamine—Dizziness—Levetiracetam—epilepsy syndrome	0.000104	0.00214	CcSEcCtD
Benzphetamine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000104	0.00213	CcSEcCtD
Benzphetamine—ADRA1A—brain—epilepsy syndrome	0.000103	0.00489	CbGeAlD
Benzphetamine—CYP2B6—central nervous system—epilepsy syndrome	0.000102	0.00488	CbGeAlD
Benzphetamine—Headache—Propofol—epilepsy syndrome	0.000102	0.0021	CcSEcCtD
Benzphetamine—ADRA2A—nervous system—epilepsy syndrome	0.000102	0.00486	CbGeAlD
Benzphetamine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000102	0.00209	CcSEcCtD
Benzphetamine—Bepridil—CACNA2D2—epilepsy syndrome	0.000102	0.0418	CrCbGaD
Benzphetamine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000102	0.00208	CcSEcCtD
Benzphetamine—Tremor—Pregabalin—epilepsy syndrome	0.000101	0.00207	CcSEcCtD
Benzphetamine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000101	0.00206	CcSEcCtD
Benzphetamine—Urticaria—Carbamazepine—epilepsy syndrome	0.0001	0.00206	CcSEcCtD
Benzphetamine—Headache—Midazolam—epilepsy syndrome	0.0001	0.00205	CcSEcCtD
Benzphetamine—Diarrhoea—Diazepam—epilepsy syndrome	9.99e-05	0.00205	CcSEcCtD
Benzphetamine—Agitation—Pregabalin—epilepsy syndrome	9.89e-05	0.00203	CcSEcCtD
Benzphetamine—Headache—Levetiracetam—epilepsy syndrome	9.88e-05	0.00202	CcSEcCtD
Benzphetamine—ADRA2A—central nervous system—epilepsy syndrome	9.83e-05	0.00468	CbGeAlD
Benzphetamine—Hypersensitivity—Clonazepam—epilepsy syndrome	9.83e-05	0.00201	CcSEcCtD
Benzphetamine—Dizziness—Vigabatrin—epilepsy syndrome	9.81e-05	0.00201	CcSEcCtD
Benzphetamine—Hypersensitivity—Phenytoin—epilepsy syndrome	9.76e-05	0.002	CcSEcCtD
Benzphetamine—Urticaria—Lamotrigine—epilepsy syndrome	9.71e-05	0.00199	CcSEcCtD
Benzphetamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.71e-05	0.00199	CcSEcCtD
Benzphetamine—Nausea—Propofol—epilepsy syndrome	9.7e-05	0.00199	CcSEcCtD
Benzphetamine—Diarrhoea—Felbamate—epilepsy syndrome	9.67e-05	0.00198	CcSEcCtD
Benzphetamine—Dizziness—Diazepam—epilepsy syndrome	9.66e-05	0.00198	CcSEcCtD
Benzphetamine—Bepridil—CACNA1A—epilepsy syndrome	9.64e-05	0.0396	CrCbGaD
Benzphetamine—ADRA2A—cerebellum—epilepsy syndrome	9.61e-05	0.00457	CbGeAlD
Benzphetamine—Headache—Fosphenytoin—epilepsy syndrome	9.54e-05	0.00195	CcSEcCtD
Benzphetamine—Palpitations—Pregabalin—epilepsy syndrome	9.51e-05	0.00195	CcSEcCtD
Benzphetamine—Nausea—Midazolam—epilepsy syndrome	9.49e-05	0.00194	CcSEcCtD
Benzphetamine—Tachycardia—Valproic Acid—epilepsy syndrome	9.48e-05	0.00194	CcSEcCtD
Benzphetamine—Diarrhoea—Zonisamide—epilepsy syndrome	9.47e-05	0.00194	CcSEcCtD
Benzphetamine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.39e-05	0.00192	CcSEcCtD
Benzphetamine—Nausea—Levetiracetam—epilepsy syndrome	9.37e-05	0.00192	CcSEcCtD
Benzphetamine—Dizziness—Felbamate—epilepsy syndrome	9.35e-05	0.00192	CcSEcCtD
Benzphetamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.32e-05	0.00191	CcSEcCtD
Benzphetamine—Headache—Vigabatrin—epilepsy syndrome	9.3e-05	0.0019	CcSEcCtD
Benzphetamine—Anorexia—Valproic Acid—epilepsy syndrome	9.26e-05	0.0019	CcSEcCtD
Benzphetamine—Tremor—Gabapentin—epilepsy syndrome	9.24e-05	0.00189	CcSEcCtD
Benzphetamine—Dizziness—Zonisamide—epilepsy syndrome	9.15e-05	0.00188	CcSEcCtD
Benzphetamine—Headache—Diazepam—epilepsy syndrome	9.15e-05	0.00188	CcSEcCtD
Benzphetamine—Diarrhoea—Clonazepam—epilepsy syndrome	9.13e-05	0.00187	CcSEcCtD
Benzphetamine—Agitation—Gabapentin—epilepsy syndrome	9.07e-05	0.00186	CcSEcCtD
Benzphetamine—Diarrhoea—Phenytoin—epilepsy syndrome	9.06e-05	0.00186	CcSEcCtD
Benzphetamine—Nausea—Fosphenytoin—epilepsy syndrome	9.04e-05	0.00185	CcSEcCtD
Benzphetamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.02e-05	0.00185	CcSEcCtD
Benzphetamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	9e-05	0.00185	CcSEcCtD
Benzphetamine—Headache—Felbamate—epilepsy syndrome	8.86e-05	0.00182	CcSEcCtD
Benzphetamine—Dizziness—Clonazepam—epilepsy syndrome	8.82e-05	0.00181	CcSEcCtD
Benzphetamine—Nausea—Vigabatrin—epilepsy syndrome	8.81e-05	0.00181	CcSEcCtD
Benzphetamine—Insomnia—Valproic Acid—epilepsy syndrome	8.78e-05	0.0018	CcSEcCtD
Benzphetamine—Dizziness—Phenytoin—epilepsy syndrome	8.76e-05	0.0018	CcSEcCtD
Benzphetamine—Palpitations—Gabapentin—epilepsy syndrome	8.72e-05	0.00179	CcSEcCtD
Benzphetamine—Dizziness—Oxcarbazepine—epilepsy syndrome	8.71e-05	0.00179	CcSEcCtD
Benzphetamine—Nausea—Diazepam—epilepsy syndrome	8.68e-05	0.00178	CcSEcCtD
Benzphetamine—Headache—Zonisamide—epilepsy syndrome	8.67e-05	0.00178	CcSEcCtD
Benzphetamine—Diarrhoea—Carbamazepine—epilepsy syndrome	8.65e-05	0.00177	CcSEcCtD
Benzphetamine—Tachycardia—Pregabalin—epilepsy syndrome	8.57e-05	0.00176	CcSEcCtD
Benzphetamine—Dyspepsia—Valproic Acid—epilepsy syndrome	8.55e-05	0.00175	CcSEcCtD
Benzphetamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.49e-05	0.00174	CcSEcCtD
Benzphetamine—Decreased appetite—Valproic Acid—epilepsy syndrome	8.44e-05	0.00173	CcSEcCtD
Benzphetamine—Nausea—Felbamate—epilepsy syndrome	8.4e-05	0.00172	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.38e-05	0.00172	CcSEcCtD
Benzphetamine—Anorexia—Pregabalin—epilepsy syndrome	8.37e-05	0.00172	CcSEcCtD
Benzphetamine—Dizziness—Carbamazepine—epilepsy syndrome	8.36e-05	0.00171	CcSEcCtD
Benzphetamine—Diarrhoea—Lamotrigine—epilepsy syndrome	8.36e-05	0.00171	CcSEcCtD
Benzphetamine—Headache—Clonazepam—epilepsy syndrome	8.36e-05	0.00171	CcSEcCtD
Benzphetamine—Headache—Phenytoin—epilepsy syndrome	8.3e-05	0.0017	CcSEcCtD
Benzphetamine—Headache—Oxcarbazepine—epilepsy syndrome	8.26e-05	0.00169	CcSEcCtD
Benzphetamine—Nausea—Zonisamide—epilepsy syndrome	8.22e-05	0.00168	CcSEcCtD
Benzphetamine—CYP2B6—brain—epilepsy syndrome	8.14e-05	0.00387	CbGeAlD
Benzphetamine—Dizziness—Lamotrigine—epilepsy syndrome	8.08e-05	0.00166	CcSEcCtD
Benzphetamine—CYP3A4—nervous system—epilepsy syndrome	8.04e-05	0.00383	CbGeAlD
Benzphetamine—Insomnia—Pregabalin—epilepsy syndrome	7.94e-05	0.00163	CcSEcCtD
Benzphetamine—Nausea—Clonazepam—epilepsy syndrome	7.92e-05	0.00162	CcSEcCtD
Benzphetamine—Headache—Carbamazepine—epilepsy syndrome	7.92e-05	0.00162	CcSEcCtD
Benzphetamine—Nausea—Phenytoin—epilepsy syndrome	7.87e-05	0.00161	CcSEcCtD
Benzphetamine—Tachycardia—Gabapentin—epilepsy syndrome	7.86e-05	0.00161	CcSEcCtD
Benzphetamine—Nausea—Oxcarbazepine—epilepsy syndrome	7.83e-05	0.0016	CcSEcCtD
Benzphetamine—ADRA2A—brain—epilepsy syndrome	7.8e-05	0.00371	CbGeAlD
Benzphetamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.78e-05	0.00159	CcSEcCtD
Benzphetamine—Tremor—Topiramate—epilepsy syndrome	7.78e-05	0.00159	CcSEcCtD
Benzphetamine—CYP3A4—central nervous system—epilepsy syndrome	7.74e-05	0.00368	CbGeAlD
Benzphetamine—Urticaria—Valproic Acid—epilepsy syndrome	7.72e-05	0.00158	CcSEcCtD
Benzphetamine—Anorexia—Gabapentin—epilepsy syndrome	7.67e-05	0.00157	CcSEcCtD
Benzphetamine—Headache—Lamotrigine—epilepsy syndrome	7.66e-05	0.00157	CcSEcCtD
Benzphetamine—Decreased appetite—Pregabalin—epilepsy syndrome	7.63e-05	0.00156	CcSEcCtD
Benzphetamine—Agitation—Topiramate—epilepsy syndrome	7.63e-05	0.00156	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.58e-05	0.00155	CcSEcCtD
Benzphetamine—Nausea—Carbamazepine—epilepsy syndrome	7.51e-05	0.00154	CcSEcCtD
Benzphetamine—Phenytoin—SCN8A—epilepsy syndrome	7.35e-05	0.0302	CrCbGaD
Benzphetamine—Palpitations—Topiramate—epilepsy syndrome	7.33e-05	0.0015	CcSEcCtD
Benzphetamine—Insomnia—Gabapentin—epilepsy syndrome	7.28e-05	0.00149	CcSEcCtD
Benzphetamine—Nausea—Lamotrigine—epilepsy syndrome	7.26e-05	0.00149	CcSEcCtD
Benzphetamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.16e-05	0.00147	CcSEcCtD
Benzphetamine—Methadyl Acetate—OPRM1—epilepsy syndrome	7.12e-05	0.0292	CrCbGaD
Benzphetamine—Dyspepsia—Gabapentin—epilepsy syndrome	7.09e-05	0.00145	CcSEcCtD
Benzphetamine—Decreased appetite—Gabapentin—epilepsy syndrome	7e-05	0.00143	CcSEcCtD
Benzphetamine—Urticaria—Pregabalin—epilepsy syndrome	6.98e-05	0.00143	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.95e-05	0.00142	CcSEcCtD
Benzphetamine—Tropicamide—CHRM3—epilepsy syndrome	6.84e-05	0.0281	CrCbGaD
Benzphetamine—Diarrhoea—Valproic Acid—epilepsy syndrome	6.65e-05	0.00136	CcSEcCtD
Benzphetamine—Tachycardia—Topiramate—epilepsy syndrome	6.61e-05	0.00135	CcSEcCtD
Benzphetamine—Hyperhidrosis—Topiramate—epilepsy syndrome	6.55e-05	0.00134	CcSEcCtD
Benzphetamine—Hypersensitivity—Pregabalin—epilepsy syndrome	6.47e-05	0.00133	CcSEcCtD
Benzphetamine—Anorexia—Topiramate—epilepsy syndrome	6.46e-05	0.00132	CcSEcCtD
Benzphetamine—Dizziness—Valproic Acid—epilepsy syndrome	6.42e-05	0.00132	CcSEcCtD
Benzphetamine—Urticaria—Gabapentin—epilepsy syndrome	6.4e-05	0.00131	CcSEcCtD
Benzphetamine—Tropicamide—CHRM1—epilepsy syndrome	6.38e-05	0.0262	CrCbGaD
Benzphetamine—Insomnia—Topiramate—epilepsy syndrome	6.13e-05	0.00126	CcSEcCtD
Benzphetamine—Headache—Valproic Acid—epilepsy syndrome	6.08e-05	0.00125	CcSEcCtD
Benzphetamine—Bepridil—CACNA1H—epilepsy syndrome	6.02e-05	0.0247	CrCbGaD
Benzphetamine—Diarrhoea—Pregabalin—epilepsy syndrome	6.01e-05	0.00123	CcSEcCtD
Benzphetamine—Dyspepsia—Topiramate—epilepsy syndrome	5.96e-05	0.00122	CcSEcCtD
Benzphetamine—Phenytoin—SCN9A—epilepsy syndrome	5.95e-05	0.0244	CrCbGaD
Benzphetamine—Hypersensitivity—Gabapentin—epilepsy syndrome	5.93e-05	0.00122	CcSEcCtD
Benzphetamine—Decreased appetite—Topiramate—epilepsy syndrome	5.89e-05	0.00121	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.85e-05	0.0012	CcSEcCtD
Benzphetamine—Dizziness—Pregabalin—epilepsy syndrome	5.81e-05	0.00119	CcSEcCtD
Benzphetamine—Nausea—Valproic Acid—epilepsy syndrome	5.77e-05	0.00118	CcSEcCtD
Benzphetamine—Phenytoin—SCN3A—epilepsy syndrome	5.69e-05	0.0234	CrCbGaD
Benzphetamine—Bepridil—CACNA1D—epilepsy syndrome	5.68e-05	0.0233	CrCbGaD
Benzphetamine—Isopropamide—CHRM3—epilepsy syndrome	5.57e-05	0.0229	CrCbGaD
Benzphetamine—Diarrhoea—Gabapentin—epilepsy syndrome	5.51e-05	0.00113	CcSEcCtD
Benzphetamine—Headache—Pregabalin—epilepsy syndrome	5.5e-05	0.00113	CcSEcCtD
Benzphetamine—Phenytoin—SCN4A—epilepsy syndrome	5.47e-05	0.0224	CrCbGaD
Benzphetamine—Urticaria—Topiramate—epilepsy syndrome	5.38e-05	0.0011	CcSEcCtD
Benzphetamine—Dizziness—Gabapentin—epilepsy syndrome	5.32e-05	0.00109	CcSEcCtD
Benzphetamine—Nausea—Pregabalin—epilepsy syndrome	5.22e-05	0.00107	CcSEcCtD
Benzphetamine—Tropicamide—CHRM2—epilepsy syndrome	5.21e-05	0.0214	CrCbGaD
Benzphetamine—Isopropamide—CHRM1—epilepsy syndrome	5.2e-05	0.0213	CrCbGaD
Benzphetamine—Doxylamine—CHRM1—epilepsy syndrome	5.2e-05	0.0213	CrCbGaD
Benzphetamine—Headache—Gabapentin—epilepsy syndrome	5.04e-05	0.00103	CcSEcCtD
Benzphetamine—Hypersensitivity—Topiramate—epilepsy syndrome	4.99e-05	0.00102	CcSEcCtD
Benzphetamine—Nausea—Gabapentin—epilepsy syndrome	4.78e-05	0.00098	CcSEcCtD
Benzphetamine—Diarrhoea—Topiramate—epilepsy syndrome	4.63e-05	0.00095	CcSEcCtD
Benzphetamine—Diphenidol—CHRM3—epilepsy syndrome	4.62e-05	0.019	CrCbGaD
Benzphetamine—Dizziness—Topiramate—epilepsy syndrome	4.48e-05	0.000918	CcSEcCtD
Benzphetamine—Orphenadrine—SCN9A—epilepsy syndrome	4.41e-05	0.0181	CrCbGaD
Benzphetamine—Diphenidol—CHRM1—epilepsy syndrome	4.31e-05	0.0177	CrCbGaD
Benzphetamine—Headache—Topiramate—epilepsy syndrome	4.24e-05	0.00087	CcSEcCtD
Benzphetamine—Orphenadrine—SCN4A—epilepsy syndrome	4.05e-05	0.0166	CrCbGaD
Benzphetamine—Nausea—Topiramate—epilepsy syndrome	4.02e-05	0.000825	CcSEcCtD
Benzphetamine—Trimethaphan—BCHE—epilepsy syndrome	4.01e-05	0.0165	CrCbGaD
Benzphetamine—Phenytoin—SCN1A—epilepsy syndrome	3.99e-05	0.0164	CrCbGaD
Benzphetamine—Benzatropine—CHRM1—epilepsy syndrome	3.79e-05	0.0156	CrCbGaD
Benzphetamine—Ethopropazine—CHRM1—epilepsy syndrome	3.75e-05	0.0154	CrCbGaD
Benzphetamine—Phenytoin—SCN2A—epilepsy syndrome	3.52e-05	0.0145	CrCbGaD
Benzphetamine—Diphenidol—CHRM2—epilepsy syndrome	3.52e-05	0.0144	CrCbGaD
Benzphetamine—Dextropropoxyphene—OPRD1—epilepsy syndrome	3.5e-05	0.0144	CrCbGaD
Benzphetamine—Fentanyl—OPRD1—epilepsy syndrome	3.46e-05	0.0142	CrCbGaD
Benzphetamine—Levomethadyl Acetate—OPRM1—epilepsy syndrome	3.1e-05	0.0127	CrCbGaD
Benzphetamine—Benzatropine—CHRM2—epilepsy syndrome	3.1e-05	0.0127	CrCbGaD
Benzphetamine—Ethopropazine—CHRM2—epilepsy syndrome	3.06e-05	0.0126	CrCbGaD
Benzphetamine—Orphenadrine—SCN1A—epilepsy syndrome	2.96e-05	0.0122	CrCbGaD
Benzphetamine—Dextropropoxyphene—OPRM1—epilepsy syndrome	2.68e-05	0.011	CrCbGaD
Benzphetamine—Fentanyl—OPRM1—epilepsy syndrome	2.65e-05	0.0109	CrCbGaD
Benzphetamine—Ethopropazine—BCHE—epilepsy syndrome	2.55e-05	0.0105	CrCbGaD
Benzphetamine—Methadone—OPRD1—epilepsy syndrome	2.37e-05	0.00975	CrCbGaD
Benzphetamine—Promethazine—CHRM3—epilepsy syndrome	2.05e-05	0.00842	CrCbGaD
Benzphetamine—Promethazine—CHRM1—epilepsy syndrome	1.91e-05	0.00785	CrCbGaD
Benzphetamine—Benzatropine—CYP2C19—epilepsy syndrome	1.91e-05	0.00785	CrCbGaD
Benzphetamine—Tripelennamine—CYP2D6—epilepsy syndrome	1.85e-05	0.00759	CrCbGaD
Benzphetamine—Methadone—OPRM1—epilepsy syndrome	1.82e-05	0.00746	CrCbGaD
Benzphetamine—Phenytoin—ABCC2—epilepsy syndrome	1.81e-05	0.00741	CrCbGaD
Benzphetamine—Promazine—CHRM3—epilepsy syndrome	1.8e-05	0.00741	CrCbGaD
Benzphetamine—Methamphetamine—ADRA2A—epilepsy syndrome	1.71e-05	0.00702	CrCbGaD
Benzphetamine—Oxaprozin—PTGS2—epilepsy syndrome	1.7e-05	0.00699	CrCbGaD
Benzphetamine—Promazine—CHRM1—epilepsy syndrome	1.68e-05	0.00691	CrCbGaD
Benzphetamine—Cyclobenzaprine—HTR2A—epilepsy syndrome	1.68e-05	0.00689	CrCbGaD
Benzphetamine—Phenoxybenzamine—ADRA2A—epilepsy syndrome	1.62e-05	0.00666	CrCbGaD
Benzphetamine—Selegiline—CYP2C19—epilepsy syndrome	1.61e-05	0.00659	CrCbGaD
Benzphetamine—Diphenhydramine—CHRM2—epilepsy syndrome	1.59e-05	0.00654	CrCbGaD
Benzphetamine—Promethazine—CHRM2—epilepsy syndrome	1.56e-05	0.00641	CrCbGaD
Benzphetamine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	1.54e-05	0.0063	CrCbGaD
Benzphetamine—Orphenadrine—CHRM2—epilepsy syndrome	1.51e-05	0.00618	CrCbGaD
Benzphetamine—Benzatropine—CYP2D6—epilepsy syndrome	1.42e-05	0.00582	CrCbGaD
Benzphetamine—Modafinil—CYP2C19—epilepsy syndrome	1.41e-05	0.00581	CrCbGaD
Benzphetamine—Amphetamine—SLC6A4—epilepsy syndrome	1.41e-05	0.00578	CrCbGaD
Benzphetamine—Trimipramine—ADRA2A—epilepsy syndrome	1.38e-05	0.00568	CrCbGaD
Benzphetamine—Tamoxifen—ABCC2—epilepsy syndrome	1.38e-05	0.00565	CrCbGaD
Benzphetamine—Promazine—CHRM2—epilepsy syndrome	1.37e-05	0.00564	CrCbGaD
Benzphetamine—Methamphetamine—SLC6A4—epilepsy syndrome	1.3e-05	0.00536	CrCbGaD
Benzphetamine—Atomoxetine—SLC6A4—epilepsy syndrome	1.28e-05	0.00527	CrCbGaD
Benzphetamine—Toremifene—ABCB1—epilepsy syndrome	1.27e-05	0.00521	CrCbGaD
Benzphetamine—Phenytoin—CYP2C19—epilepsy syndrome	1.25e-05	0.00515	CrCbGaD
Benzphetamine—Propafenone—CYP2D6—epilepsy syndrome	1.25e-05	0.00514	CrCbGaD
Benzphetamine—Dextroamphetamine—CYP2D6—epilepsy syndrome	1.23e-05	0.00504	CrCbGaD
Benzphetamine—Tamoxifen—ABCG2—epilepsy syndrome	1.22e-05	0.005	CrCbGaD
Benzphetamine—Atomoxetine—CYP2C19—epilepsy syndrome	1.22e-05	0.005	CrCbGaD
Benzphetamine—Selegiline—CYP2D6—epilepsy syndrome	1.19e-05	0.00489	CrCbGaD
Benzphetamine—Promazine—ADRA2A—epilepsy syndrome	1.17e-05	0.00481	CrCbGaD
Benzphetamine—Phenylbutazone—PTGS2—epilepsy syndrome	1.12e-05	0.00462	CrCbGaD
Benzphetamine—Bepridil—CYP2D6—epilepsy syndrome	1.12e-05	0.00458	CrCbGaD
Benzphetamine—Phenprocoumon—ALB—epilepsy syndrome	1.08e-05	0.00443	CrCbGaD
Benzphetamine—Trimipramine—SLC6A4—epilepsy syndrome	1.06e-05	0.00434	CrCbGaD
Benzphetamine—Dextropropoxyphene—CYP2D6—epilepsy syndrome	1.04e-05	0.00426	CrCbGaD
Benzphetamine—Trimipramine—CYP2C19—epilepsy syndrome	1e-05	0.00411	CrCbGaD
Benzphetamine—Amphetamine—CYP2D6—epilepsy syndrome	9.89e-06	0.00406	CrCbGaD
Benzphetamine—Atomoxetine—HTR2A—epilepsy syndrome	9.86e-06	0.00405	CrCbGaD
Benzphetamine—Diphenhydramine—CYP2C19—epilepsy syndrome	9.83e-06	0.00404	CrCbGaD
Benzphetamine—Tamoxifen—CYP2C19—epilepsy syndrome	9.57e-06	0.00393	CrCbGaD
Benzphetamine—Methadone—CYP2C19—epilepsy syndrome	9.49e-06	0.0039	CrCbGaD
Benzphetamine—Methamphetamine—CYP2D6—epilepsy syndrome	9.17e-06	0.00376	CrCbGaD
Benzphetamine—Atomoxetine—CYP2D6—epilepsy syndrome	9.02e-06	0.0037	CrCbGaD
Benzphetamine—Propafenone—ABCB1—epilepsy syndrome	8.94e-06	0.00367	CrCbGaD
Benzphetamine—Selegiline—ABCB1—epilepsy syndrome	8.5e-06	0.00349	CrCbGaD
Benzphetamine—Promazine—CYP2C19—epilepsy syndrome	8.48e-06	0.00348	CrCbGaD
Benzphetamine—Trimipramine—HTR2A—epilepsy syndrome	8.11e-06	0.00333	CrCbGaD
Benzphetamine—Bepridil—ABCB1—epilepsy syndrome	7.97e-06	0.00327	CrCbGaD
Benzphetamine—Promethazine—HTR2A—epilepsy syndrome	7.81e-06	0.00321	CrCbGaD
Benzphetamine—Trimipramine—CYP2D6—epilepsy syndrome	7.42e-06	0.00305	CrCbGaD
Benzphetamine—Fentanyl—ABCB1—epilepsy syndrome	7.32e-06	0.00301	CrCbGaD
Benzphetamine—Diphenhydramine—CYP2D6—epilepsy syndrome	7.29e-06	0.00299	CrCbGaD
Benzphetamine—Promethazine—CYP2D6—epilepsy syndrome	7.14e-06	0.00293	CrCbGaD
Benzphetamine—Tamoxifen—CYP2D6—epilepsy syndrome	7.09e-06	0.00291	CrCbGaD
Benzphetamine—Methadone—CYP2D6—epilepsy syndrome	7.03e-06	0.00289	CrCbGaD
Benzphetamine—Phenytoin—ALB—epilepsy syndrome	6.96e-06	0.00286	CrCbGaD
Benzphetamine—Promazine—HTR2A—epilepsy syndrome	6.87e-06	0.00282	CrCbGaD
Benzphetamine—Phenytoin—ABCB1—epilepsy syndrome	6.64e-06	0.00273	CrCbGaD
Benzphetamine—Trimipramine—ABCB1—epilepsy syndrome	5.3e-06	0.00218	CrCbGaD
Benzphetamine—Promethazine—ABCB1—epilepsy syndrome	5.1e-06	0.00209	CrCbGaD
Benzphetamine—Tamoxifen—ABCB1—epilepsy syndrome	5.07e-06	0.00208	CrCbGaD
Benzphetamine—Methadone—ABCB1—epilepsy syndrome	5.02e-06	0.00206	CrCbGaD
Benzphetamine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.48e-06	8.34e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CX3CR1—epilepsy syndrome	3.45e-06	8.28e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HBEGF—epilepsy syndrome	3.43e-06	8.23e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CX3CL1—epilepsy syndrome	3.39e-06	8.12e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CHRM2—epilepsy syndrome	3.39e-06	8.12e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BDKRB1—epilepsy syndrome	3.39e-06	8.12e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CDC42—epilepsy syndrome	3.38e-06	8.11e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GFAP—epilepsy syndrome	3.38e-06	8.11e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GAL—epilepsy syndrome	3.38e-06	8.11e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT3—epilepsy syndrome	3.37e-06	8.08e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CHRM3—epilepsy syndrome	3.35e-06	8.02e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP2—epilepsy syndrome	3.35e-06	8.02e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GRM5—epilepsy syndrome	3.35e-06	8.02e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CDC42—epilepsy syndrome	3.31e-06	7.93e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GABBR1—epilepsy syndrome	3.29e-06	7.9e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.28e-06	7.87e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AVP—epilepsy syndrome	3.28e-06	7.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCG2—epilepsy syndrome	3.26e-06	7.82e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CX3CR1—epilepsy syndrome	3.21e-06	7.69e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AVP—epilepsy syndrome	3.2e-06	7.68e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP2C19—epilepsy syndrome	3.18e-06	7.62e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP11A1—epilepsy syndrome	3.16e-06	7.57e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HRH3—epilepsy syndrome	3.16e-06	7.57e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BDKRB1—epilepsy syndrome	3.15e-06	7.54e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CX3CL1—epilepsy syndrome	3.15e-06	7.54e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CHRM2—epilepsy syndrome	3.15e-06	7.54e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—ALB—epilepsy syndrome	3.14e-06	7.53e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.11e-06	7.46e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.11e-06	7.46e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.11e-06	7.46e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.11e-06	7.46e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.11e-06	7.46e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—OPRM1—epilepsy syndrome	3.11e-06	7.45e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CDC42—epilepsy syndrome	3.07e-06	7.37e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GABBR1—epilepsy syndrome	3.06e-06	7.34e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	3.06e-06	7.33e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CCR5—epilepsy syndrome	3e-06	7.19e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	2.98e-06	7.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AVP—epilepsy syndrome	2.98e-06	7.13e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	2.96e-06	7.1e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR3—epilepsy syndrome	2.94e-06	7.04e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.93e-06	7.04e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HRH3—epilepsy syndrome	2.93e-06	7.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—OPRM1—epilepsy syndrome	2.89e-06	6.93e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NPY—epilepsy syndrome	2.86e-06	6.86e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.86e-06	6.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP2D6—epilepsy syndrome	2.85e-06	6.84e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.85e-06	6.82e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.85e-06	6.82e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.85e-06	6.82e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	2.79e-06	6.68e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	2.78e-06	6.68e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	2.76e-06	6.62e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	2.76e-06	6.62e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	2.76e-06	6.62e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	2.76e-06	6.62e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	2.76e-06	6.62e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.74e-06	6.57e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	2.73e-06	6.54e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.73e-06	6.54e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	2.72e-06	6.53e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—BCHE—epilepsy syndrome	2.7e-06	6.48e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.68e-06	6.42e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.67e-06	6.41e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.67e-06	6.39e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	2.66e-06	6.37e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.66e-06	6.37e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.65e-06	6.34e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.65e-06	6.34e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	2.59e-06	6.2e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	2.58e-06	6.18e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.57e-06	6.17e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	2.57e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	2.57e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	2.56e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	2.56e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	2.56e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	2.56e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	2.56e-06	6.15e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	2.55e-06	6.12e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.55e-06	6.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TH—epilepsy syndrome	2.54e-06	6.09e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.53e-06	6.08e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	2.53e-06	6.07e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	2.53e-06	6.06e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	2.5e-06	5.98e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	2.5e-06	5.98e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	2.5e-06	5.98e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.49e-06	5.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.48e-06	5.94e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	2.47e-06	5.93e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.44e-06	5.86e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	2.43e-06	5.83e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.42e-06	5.8e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.42e-06	5.8e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.39e-06	5.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.39e-06	5.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	2.38e-06	5.72e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	2.38e-06	5.72e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TH—epilepsy syndrome	2.38e-06	5.71e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.36e-06	5.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.36e-06	5.65e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	2.35e-06	5.63e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.35e-06	5.63e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	2.35e-06	5.63e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	2.34e-06	5.62e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.34e-06	5.6e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.33e-06	5.58e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	2.32e-06	5.56e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	2.32e-06	5.56e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	2.32e-06	5.56e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	2.3e-06	5.52e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	2.3e-06	5.52e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	2.3e-06	5.51e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	2.3e-06	5.5e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	2.26e-06	5.42e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.25e-06	5.39e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.25e-06	5.39e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	2.25e-06	5.39e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	2.22e-06	5.33e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.2e-06	5.28e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.18e-06	5.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.18e-06	5.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	2.18e-06	5.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	2.18e-06	5.22e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.17e-06	5.2e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	2.17e-06	5.19e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.16e-06	5.18e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.16e-06	5.17e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	2.14e-06	5.13e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	2.14e-06	5.13e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	2.14e-06	5.13e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.13e-06	5.11e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	2.13e-06	5.1e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	2.12e-06	5.09e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.12e-06	5.07e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAT—epilepsy syndrome	2.09e-06	5.02e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.09e-06	5.02e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	2.09e-06	5.01e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.08e-06	4.99e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.08e-06	4.98e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	2.04e-06	4.88e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	2.03e-06	4.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	1.99e-06	4.77e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.99e-06	4.77e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	1.98e-06	4.74e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	1.98e-06	4.74e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.96e-06	4.7e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.96e-06	4.7e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.95e-06	4.68e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.94e-06	4.66e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.94e-06	4.66e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.93e-06	4.64e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.91e-06	4.58e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	1.89e-06	4.54e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.89e-06	4.54e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.89e-06	4.52e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	1.84e-06	4.41e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.82e-06	4.36e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.82e-06	4.35e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.79e-06	4.29e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.77e-06	4.25e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.76e-06	4.21e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.74e-06	4.17e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.73e-06	4.16e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.73e-06	4.15e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.71e-06	4.09e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.71e-06	4.09e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.67e-06	4.01e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.66e-06	3.99e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.66e-06	3.98e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.65e-06	3.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.63e-06	3.9e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.62e-06	3.88e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.61e-06	3.86e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.61e-06	3.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.61e-06	3.85e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.57e-06	3.77e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.56e-06	3.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.55e-06	3.73e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.54e-06	3.68e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.52e-06	3.66e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.5e-06	3.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.49e-06	3.58e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.49e-06	3.58e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.46e-06	3.51e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.46e-06	3.51e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.43e-06	3.44e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.4e-06	3.35e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.39e-06	3.33e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.39e-06	3.33e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.39e-06	3.33e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.38e-06	3.31e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.38e-06	3.31e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.37e-06	3.3e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.36e-06	3.26e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.35e-06	3.25e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.35e-06	3.23e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.33e-06	3.19e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.31e-06	3.14e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.28e-06	3.07e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.28e-06	3.06e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.27e-06	3.05e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.26e-06	3.01e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.23e-06	2.95e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.21e-06	2.91e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.19e-06	2.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.17e-06	2.8e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.16e-06	2.77e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.15e-06	2.76e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.14e-06	2.74e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.11e-06	2.67e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.11e-06	2.67e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.1e-06	2.63e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.09e-06	2.61e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.08e-06	2.6e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.04e-06	2.5e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.03e-06	2.48e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.03e-06	2.47e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-06	2.43e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	9.59e-07	2.3e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	9.4e-07	2.25e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.4e-07	2.25e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	9.31e-07	2.23e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	9.04e-07	2.17e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.04e-07	2.17e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.92e-07	2.14e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	8.8e-07	2.11e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.73e-07	2.09e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	8.67e-07	2.08e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	8.65e-07	2.07e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	8.53e-07	2.05e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	8.4e-07	2.01e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	8.17e-07	1.96e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	8.11e-07	1.94e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.06e-07	1.93e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	7.93e-07	1.9e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.9e-07	1.89e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	7.54e-07	1.81e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.34e-07	1.76e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.07e-07	1.7e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.93e-07	1.66e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.95e-07	1.43e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	5.6e-07	1.34e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.43e-07	1.3e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	5.25e-07	1.26e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	5.04e-07	1.21e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.75e-07	1.14e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	4.68e-07	1.12e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.39e-07	5.72e-06	CbGpPWpGaD
